Fact-checked by Grok 2 weeks ago

Ventilator

A ventilator, also known as a ventilator, is a that provides by delivering positive pressure breaths of air or oxygen-enriched gas into the lungs to assist or replace spontaneous breathing in patients unable to maintain adequate ventilation independently, such as those with acute or during under general . These devices control parameters like , , and (PEEP) to optimize while minimizing risks such as ventilator-induced lung injury from overdistension or atelectrauma. The evolution of ventilators traces back to 16th-century experiments with for , progressing to negative-pressure "iron lungs" in the early 20th century for victims, before positive-pressure systems emerged in the 1940s and became standard in intensive care following widespread adoption during mid-century epidemics. Modern microprocessor-controlled ventilators incorporate advanced modes, including pressure support and adaptive algorithms, enabling tailored support for diverse conditions like (ARDS), where lung-protective strategies—such as low tidal volumes—have demonstrably reduced mortality based on randomized trials. While ventilators sustain life in critical settings, their use entails empirical risks including , hemodynamic instability, and , prompting debates on initiation timing, noninvasive alternatives, and protocols to balance benefits against iatrogenic harm. underscores the importance of minimizing ventilator days through evidence-based liberation strategies, as prolonged dependence correlates with higher complication rates in peer-reviewed analyses.

Principles of Operation

Core Mechanisms

Mechanical ventilators primarily employ positive-pressure ventilation to deliver breaths, generating a that forces gas into the patient's s, in contrast to the negative-pressure mechanism of spontaneous where thoracic expansion creates subatmospheric to draw air inward. This active inflation expands the alveoli, enabling oxygen uptake and elimination by overcoming and . The process requires precise control to avoid , with representing the maximum force needed to deliver the against resistive and elastic loads. Central to operation is the generator, typically a , , or compressed gas source, which produces the necessary airflow rates—often up to 60-120 liters per minute for adults—while a orchestrates timing and delivery via valves that open during inspiration to direct gas through the circuit and close to permit . Sensors continuously measure airway , gas , and delivered using differential transducers and hot-wire anemometers, feeding data back to the to adjust for patient-specific lung mechanics, such as (volume change per unit , normally 50-100 mL/cm H2O) and resistance (typically 5-15 cm H2O/L/s). Expiratory valves maintain (PEEP, usually 5-10 cm H2O) to prevent alveolar collapse, ensuring recruitment of lung units for improved oxygenation. Breaths are cycled between inspiratory and expiratory phases, with inspiration terminating upon reaching a target (4-8 mL/kg ideal body weight), pressure limit (often 30-35 cm H2O), time interval, or flow deceleration, followed by passive expiration driven by until flow ceases or a minimum time elapses. This intermittent positive-pressure approach, standard since the mid-20th century, minimizes circulatory interference compared to negative-pressure systems by reducing mean intrathoracic pressure swings, though it risks hemodynamic compromise if excessive pressures impede venous return. Alarms and safeguards monitor for deviations, such as indicating obstruction or low volume signaling disconnection, ensuring operational integrity.

Ventilation Modes and Parameters

Ventilation modes in mechanical ventilators dictate the timing, triggering, and delivery of breaths, broadly classified into volume-controlled and -controlled categories, with and advanced modes available for specific clinical needs. Volume-controlled modes, such as volume-controlled (VC-CMV), deliver a preset regardless of airway variations, which can rise if decreases or increases, potentially risking if pressures exceed safe limits. Pressure-controlled modes, including pressure-controlled (PC-CMV), apply a fixed inspiratory limit, resulting in variable volumes influenced by mechanics, which may benefit patients with heterogeneous injury by limiting peak pressures. Assist-control (A/C) modes, available in both volume and variants, provide mandatory breaths at a set rate but allow patient-triggered breaths above this minimum, augmenting spontaneous efforts with full ventilator support to reduce . Synchronized intermittent mandatory ventilation (SIMV) combines mandatory breaths synchronized to patient effort with unsupported spontaneous breaths, often paired with pressure support to augment the latter and improve patient-ventilator synchrony, though it may increase work of breathing compared to full support modes if spontaneous efforts are weak. Pressure support ventilation (PSV) is a spontaneous breathing mode where the ventilator assists patient-initiated breaths by providing a constant pressure during inspiration until flow decreases to a set threshold, typically used for weaning as it promotes patient control over respiratory rate and tidal volume. Advanced modes like airway pressure release ventilation (APRV) alternate between high and low pressures with prolonged high-pressure phases to maintain mean airway pressure for oxygenation while permitting spontaneous breathing, adjusting parameters such as P-high (typically 20-30 cm H2O), T-high (4-6 seconds), P-low (0-5 cm H2O), and T-low (0.5-0.8 seconds). Hybrid modes, such as pressure-regulated volume control (PRVC), target a set tidal volume by automatically adjusting pressure limits breath-to-breath, combining volume assurance with pressure safety. ![Ventilator pressures labeled.png][float-right] Key parameters govern breath delivery and , with initial settings tailored to patient physiology to optimize while minimizing ventilator-induced lung injury (VILI). (Vt) is set at 6-8 mL/kg of predicted body weight in lung-protective strategies, reduced from historical 10-12 mL/kg following evidence that lower volumes decrease mortality in (ARDS) by limiting volutrauma and biotrauma. (RR) typically starts at 12-20 breaths per minute, adjusted to achieve a of 6-8 L/min while avoiding auto-PEEP from incomplete exhalation, particularly in . (PEEP) maintains alveolar recruitment at 5-15 cm H2O, titrated via oxygenation response or esophageal to counter atelectrauma without overdistension, as higher levels improve oxygenation but risk hemodynamic compromise. Fraction of inspired oxygen (FiO2) begins at 0.4-0.6 and is minimized to ≤0.6 to prevent oxygen toxicity, paired with PEEP adjustments to achieve SpO2 88-95% or PaO2 55-80 mmHg in ARDS protocols. Inspiratory-to-expiratory (I:E) ratio is usually 1:2 to allow sufficient expiratory time, modifiable in inverse ratio ventilation (e.g., 2:1) for pressure-controlled modes to enhance mean airway pressure and oxygenation in refractory hypoxemia. Peak inspiratory pressure (PIP) is monitored (goal <30-35 cm H2O) as a surrogate for alveolar pressure, with plateau pressure (Pplat) <30 cm H2O confirming safe transpulmonary stress; flow rate (50-80 L/min) influences inspiratory time and patient comfort in volume modes. Pressure support levels in PSV range 5-20 cm H2O above PEEP, titrated to achieve Vt 6-8 mL/kg spontaneously, facilitating weaning trials when patients tolerate minimal support.
ParameterTypical Initial SettingPrimary GoalCitation
Tidal Volume (Vt)6-8 mL/kg predicted body weightPrevent VILI while ensuring ventilation
Respiratory Rate (RR)12-20 breaths/minAchieve adequate minute ventilation
PEEP5-15 cm H2OAlveolar recruitment and oxygenation
FiO20.4-0.6Oxygenation with minimal toxicity
I:E Ratio1:2Balance inspiration and expiration

Safety and Monitoring Features

Mechanical ventilators integrate safety features and monitoring systems to prevent complications like barotrauma, hypoxia, and circuit failures, with alarms designed to alert clinicians to deviations in real-time parameters. These systems comply with standards such as , which specifies requirements for basic safety and essential performance, including reliable alarm functionality and protective mechanisms. Alarms are categorized by pressure, volume, rate, and oxygenation, triggering audible and visual signals when thresholds are breached. High pressure alarms activate above limits like 35 cmH₂O peak inspiratory pressure to avert lung overdistension, often terminating the inspiratory phase. Low pressure alarms signal below 2 cmH₂O above PEEP, indicating potential leaks, disconnections, or cuff failures. Volume-related alarms monitor tidal and minute volumes, with low minute volume alerts below 3-4 L/min detecting hypoventilation, while high minute volume exceeds 20 L/min in spontaneous modes. Apnea alarms trigger after 20 seconds of absent breaths, and high respiratory rate alarms sound above 30-35 breaths per minute. Monitoring capabilities display scalar parameters including peak inspiratory pressure (PIP), plateau pressure (Pplat), driving pressure (ΔP), positive end-expiratory pressure (PEEP), tidal volume, respiratory rate, and FiO₂, allowing assessment of compliance, resistance, and ventilation-perfusion matching. Waveform graphics plot pressure, flow, and volume against time, revealing issues like auto-PEEP or patient-ventilator asynchrony through loop analysis. Fail-safe mechanisms include pressure relief valves, backup battery operation for power loss, and automatic transitions to ambient or manual ventilation modes during equipment faults, ensuring continuity of support. Pre-use checks verify circuit integrity and alarm readiness, with capnography and pulse oximetry providing adjunctive confirmation of endotracheal tube placement and oxygenation adequacy.

Types of Ventilators

Invasive Mechanical Ventilators

Invasive mechanical ventilators provide positive pressure ventilation via an artificial airway, such as an endotracheal tube (ETT) or tracheostomy tube, to support gas exchange in patients with inadequate spontaneous breathing. This approach secures the airway and enables full mechanical control of tidal volume, respiratory rate, and pressure levels, distinguishing it from non-invasive ventilation that relies on masks or nasal interfaces. The system comprises the ventilator unit, which mixes and delivers oxygen-enriched gas, a patient circuit for tubing and humidification, and sensors for monitoring airway pressures and flow. Primary indications include acute respiratory failure (hypoxemic or hypercapnic), airway protection in comatose or obtunded patients, hemodynamic instability with shock, and general anesthesia during surgery. In intensive care units, invasive ventilation sustains life in approximately 310 adults per 100,000 population annually in the United States.30324-5/fulltext) Ventilators operate in controlled modes to deliver preset breaths or assist spontaneous efforts, with microprocessor-based systems allowing precise adjustments to minimize risks like volutrauma. Complications arise from the invasive interface and positive pressure mechanics, including ventilator-associated pneumonia (VAP) affecting up to 13% of patients, barotrauma from excessive pressures, and ventilator-induced lung injury (VILI) via mechanisms such as overdistension or cyclic atelectasis. ICU mortality rates for invasively ventilated patients range from 30% to 52%, influenced by underlying conditions like cardiac arrest or sepsis. Prolonged use (>48 hours) elevates infection risk due to formation on the ETT, necessitating protocols for , positioning, and to mitigate adverse effects. Modern units incorporate alarms for high/low pressures and oxygen desaturation to enhance safety, though human factors in setup contribute to errors.

Non-Invasive Ventilators

Non-invasive ventilators deliver positive pressure respiratory support through external interfaces such as nasal masks, full-face masks, or nasal prongs, without requiring endotracheal or tracheostomy. This approach augments alveolar ventilation, reduces the , and improves by maintaining during inspiration and expiration, thereby preventing alveolar collapse and enhancing oxygenation. Unlike invasive methods, non-invasive ventilation preserves natural airway defense mechanisms, including and , as the upper airway remains intact. Common modes include (CPAP), which applies a fixed pressure level throughout the respiratory cycle to stent open airways and counteract obstructive collapse, and bilevel (BiPAP), which alternates between higher inspiratory (IPAP) for support and lower expiratory (EPAP) for oxygenation. CPAP is particularly effective for hypoxemic conditions like or cardiogenic , where it reduces preload and on the heart, as demonstrated in randomized controlled trials showing decreased rates and mortality compared to standard . BiPAP, providing ventilatory assistance via pressure support, is preferred for hypercapnic respiratory failure, such as in (COPD) exacerbations, with Cochrane reviews of 14 trials indicating significant reductions in (odds ratio 0.41), hospital stay length, and complications. Interfaces must ensure a tight seal to minimize leaks while allowing comfort and communication; options include oronasal masks for acute settings and nasal pillows for home use. selection is critical, favoring cooperative individuals without excessive secretions, risk, or altered , as NIV failure rates exceed 30-50% in unsuitable cases like severe or . Advantages encompass lower risks of (incidence reduced by up to 70% versus invasive ventilation), shorter intensive care stays, and cost savings from avoided procedures, supported by meta-analyses in acute cardiogenic and COPD. Limitations include intolerance leading to discontinuation in 20-30% of patients, potential for gastric causing discomfort, and delayed invasive intervention if failure occurs, which can worsen outcomes in rapid . Monitoring involves continuous assessment of , oxygen saturation, gases, and patient comfort, with failure predictors including persistent (>25 breaths/min) or pH <7.25 after 1-2 hours of therapy. In chronic settings, home NIV via portable devices improves survival in neuromuscular diseases like amyotrophic lateral sclerosis, with survival benefits evident in trials extending median time by 7-12 months.

Specialized and Portable Variants

Portable ventilators are compact, battery-powered devices engineered for mobility, enabling mechanical ventilation during patient transport, in ambulances, helicopters, or home settings where fixed ICU equipment is impractical. These units typically weigh 5-15 kg, offer runtime of 4-8 hours on internal batteries (extendable with external power), and support both invasive and noninvasive modes including pressure control, volume control, and / for chronic respiratory failure. Examples include the Philips Respironics Trilogy series, which provides adaptive servoventilation for weaning and weighs under 6 kg, and the ResMed Astral 150, designed for pediatric and adult home use with integrated humidification and leak compensation. Transport-specific variants, such as the ZOLL EMV+, incorporate rugged casings for field durability, GPS integration for logistics, and compatibility with compressed gas for extended operation in resource-limited environments like disaster response. Specialized ventilators address niche clinical demands beyond standard adult ICU applications. Neonatal variants, tailored for preterm infants with compliant lungs prone to injury, deliver microliter-precise tidal volumes (as low as 2 mL) and frequencies up to 900 breaths per minute in high-frequency oscillatory () or jet ventilation () modes to minimize volutrauma while optimizing gas exchange. Devices like the Dräger Babylog emphasize lung-protective strategies, including volume guarantee and automated leak compensation during nasal CPAP, reducing bronchopulmonary dysplasia risk in ventilated neonates by maintaining target volumes despite circuit leaks up to 80%. These differ from adult models by incorporating smaller tubing, integrated blenders for FiO2 titration from 21-100%, and developmental care features like minimized noise and vibration. Other specialized types include anesthesia ventilators, which integrate with operating room systems for precise gas mixing (e.g., volatile agents) and rapid cycle times during surgery, and military/field units like gas-powered models (e.g., ventiPAC) that operate without electricity using oxygen or air cylinders for austere environments. Hybrid portable-specialized devices, such as the Ventec VOCSN, combine ventilation with oxygen concentration and suction in a single 5 kg unit for prolonged field or home support. Empirical data from transport studies indicate these variants maintain oxygenation stability (SpO2 >92%) in 95% of intra-hospital moves, though battery depletion and vibration-induced alarms remain challenges requiring redundant power protocols.

Historical Development

Pre-20th Century Foundations

The earliest foundations of emerged from anatomical experiments and efforts aimed at restoring spontaneous breathing in cases of , such as or suffocation. Biblical accounts, including 2 Kings 4:34 (circa 800 BCE), describe rudimentary manual methods akin to mouth-to-mouth or body-to-body contact for revival, though these lack empirical validation as systematic techniques. By the , Swiss physician (1493–1541) proposed using to inflate the lungs, drawing from tools to mimic respiratory , though primarily conceptual rather than clinically applied. A pivotal advancement occurred in 1555 when anatomist (1514–1564) conducted experiments on living animals, inserting a into the trachea and using double fireplace bellows to deliver rhythmic air , successfully maintaining circulation and demonstrating that lung inflation could sustain life independently of diaphragmatic action. This positive-pressure approach, detailed in De Humani Corporis Fabrica, established core principles of mechanical airway support but was limited to and not human use due to ethical and technical constraints. highlighted the trachea as an access route for ventilation, influencing later devices. In the , rising incidents prompted organized efforts, with the Society for the Recovery of Drowned Persons (founded 1767) endorsing bellows inserted via mouth or nostrils to force air into the lungs, often combined with enemas for stimulation. Similar initiatives by the Royal Humane Society (1774) in standardized such methods, though critiques arose over risks like from excessive pressure or gastric distension. Manual alternatives gained traction, including John Fothergill's 1744 advocacy for warming and friction alongside , but bellows persisted as a mechanical prototype despite inconsistent efficacy. The 19th century shifted toward manual chest expansion techniques, supplanting bellows due to portability and simplicity, yet laying groundwork for mechanical evolution. Marshall Hall's 1856 "direct method" involved rolling the prone body to expel and draw air via abdominal pressure, while Henry Silvester's 1858 arm-lift and compression maneuver expanded the rhythmically. Early negative-pressure concepts emerged, with devices like Jules Woillez's 1876 "Spirophore"—a rocking iron that alternately compressed and decompressed the chest—foreshadowing enclosure-based without . These pre-20th century innovations prioritized empirical restoration of over sustained mechanical support, constrained by absent and controls, but validated causal links between forced and alveolar renewal essential to later ventilators.

Negative-Pressure Systems

Negative-pressure ventilation systems emerged as the earliest practical respirators in the early , relying on external to mimic natural breathing by expanding the chest wall. These devices applied intermittent subatmospheric pressure to the body or portions thereof, creating a that drew air into the lungs during inspiration, followed by relaxation to allow expiration. Unlike later positive-pressure methods, this approach avoided direct airway instrumentation, reducing risks of but limiting in patients with impaired chest compliance. The foundational device, known as the Drinker respirator or "," was invented in 1928 by Philip Drinker, an industrial hygienist, and Louis Agassiz Shaw, a physiologist, at . This tank respirator encased the patient's body up to the neck in an airtight cylindrical chamber, with an electrically driven pump generating negative pressures of -10 to -25 cmH2O cyclically. The first clinical success occurred on October 12, 1928, when it sustained an eight-year-old girl with respiratory paralysis from at , marking the device's viability for prolonged support. By 1930, production scaled, with units costing around $1,500 each, and it became standard for polio epidemics that peaked in the 1940s and 1950s, sustaining thousands despite the disease's high morbidity. Improvements by John Haven Emerson in the addressed the original's bulkiness and inaccessibility; his 1932 design weighed 600 pounds versus 1,000 for the Drinker model, incorporated transparent head ports for nursing access, and cost under $500, enabling widespread adoption. Emerson's variants included the rocking bed (), which used gravity-assisted via body tilting, and the poncho wrap (1940s) for partial thoracic enclosure. In , the Both respirator (1937) offered a smaller, portable alternative during local polio surges. These systems proved life-sustaining, with survival rates in bulbar cases improving from near-zero to over 50% in equipped facilities by the 1940s, though , pressure sores, and inefficient ventilation in obese or kyphotic patients were common drawbacks. The vaccine's introduction in reduced demand, but negative-pressure devices persisted for home use and neuromuscular diseases into the . Their revival in modern contexts, such as shells or exoskeletal jackets, highlights advantages in noninvasive settings, though positive-pressure ventilators largely supplanted them due to superior control and portability. Empirical data from mid-20th-century outbreaks confirm their causal role in averting , with studies showing preserved pulmonary function absent mechanical aids.

Positive-Pressure Evolution

Positive-pressure ventilation, which delivers breaths by forcing air into the lungs via an endotracheal tube or mask, emerged as an alternative to negative-pressure systems in the early . In 1907, German engineer Johann Heinrich Dräger introduced the Pulmotor, an early portable device using for in cases of , asphyxiation, or ; it gained popularity for emergency use but was not designed for prolonged mechanical support. Prior to 1950, positive-pressure mechanisms remained largely confined to operating rooms for delivery, with devices like or basic piston pumps providing intermittent breaths, though they lacked precise control over volume, rate, or pressure, limiting their application beyond short-term procedures. The pivotal shift toward sustained positive-pressure occurred amid the 1952 Copenhagen poliomyelitis epidemic, where anesthesiologist Bjørn Ibsen implemented manual positive-pressure ventilation through tracheostomy tubes for over 200 patients, recruiting medical students to perform bag-valve-mask around the clock. This approach, which corrected and protected airways more effectively than iron lungs, demonstrated the feasibility of prolonged positive-pressure support, reducing mortality from near 90% to under 20% in bulbar cases and establishing the foundations of intensive care units. Ibsen's method highlighted positive pressure's advantages in oxygenation and secretion management but relied on labor-intensive manual operation, prompting the rapid development of automated alternatives. In response, Swedish physician-engineer Carl Gunnar Engström developed the Engström 100 in 1950, one of the first volume-controlled intermittent positive-pressure ventilators capable of delivering adjustable tidal volumes and respiratory rates via a piston mechanism, marking a transition to reliable mechanical delivery for ICU settings. By 1954, the Engström Model 150 incorporated inhalation anesthesia compatibility, further integrating positive-pressure systems into surgical and critical care, while other early ICU ventilators like the Mörch piston respirator emphasized controlled inflation to minimize barotrauma risks inherent in manual methods. This evolution supplanted negative-pressure devices by the 1960s, as positive-pressure enabled superior ventilatory precision, endotracheal access for suctioning, and compatibility with emerging physiological monitoring, though it introduced new challenges like volutrauma from excessive pressures.

Microprocessor and Digital Integration

The transition to microprocessor-controlled ventilators occurred in the early 1980s, defining the third generation of intensive care unit (ICU) devices and shifting from analog pneumatic systems to digital electronics for enhanced precision in gas delivery and monitoring. These systems employed microprocessors to compute and regulate parameters such as tidal volume, inspiratory flow, and pressure limits in real time, enabling closed-loop feedback that adjusted ventilation dynamically based on patient lung mechanics. This integration addressed limitations of prior generations, where fixed mechanical controls often mismatched varying patient needs, leading to risks like overdistension or inadequate support. Key early models exemplified this advancement; the Dräger EV-A, launched in 1982, introduced microprocessor-regulated gas flow and electromagnetic valves, allowing faster response times and the first incorporation of graphic waveform displays for pressure and flow visualization. Similarly, the Puritan Bennett 7200, released circa 1983, utilized digital processing for flow-triggering and pressure-controlled modes, reducing by detecting subtle patient efforts more reliably than pneumatic triggers. Other notable third-generation units included the Bear , Siemens , and Hamilton Veolar, which supported synchronized intermittent mandatory ventilation (SIMV), pressure support, and through algorithmic control. Digital integration facilitated sophisticated alarms for deviations in , peak pressures exceeding 40 cmH₂O, or disconnections, with enabling trend data logging for retrospective analysis. By the mid-1980s, these features standardized in ICUs, correlating with reduced ventilator-induced through adaptive algorithms that minimized volutrauma by titrating to changes. Empirical data from clinical adoption showed improved success rates, as modes like pressure support allowed gradual respiratory muscle retraining without abrupt parameter shifts. However, early systems required reliable power and maintenance to avoid computational failures, underscoring the causal link between hardware reliability and in ventilation.

Clinical Applications

Primary Indications

Mechanical ventilation is primarily indicated in cases of acute respiratory failure, encompassing both hypoxemic and hypercapnic subtypes, where endogenous respiratory efforts fail to sustain adequate arterial oxygenation (PaO₂ <60 mmHg on high-flow oxygen) or ventilation (PaCO₂ >50 mmHg with ). Hypoxemic failure often arises from conditions impairing gas exchange, such as (ARDS) or , while hypercapnic failure typically stems from ventilatory pump dysfunction in exacerbations of (COPD) or neuromuscular disorders like . Apnea or respiratory arrest represents an immediate indication, as seen in central nervous system insults (e.g., brainstem injury or overdose), necessitating prompt initiation to avert profound hypoxemia and acidosis; delays beyond minutes can precipitate cardiac arrest. Airway protection is a core indication when consciousness is impaired (e.g., Glasgow Coma Scale <8 from trauma, stroke, or sedation), preventing aspiration of secretions or gastric contents, which empirical data link to higher pneumonia rates in unprotected patients.30324-5/fulltext) Excessive respiratory workload, evidenced by tachypnea (>30 breaths/min), accessory muscle use, or fatigue in conditions like severe or status asthmaticus, warrants ventilation to avert , with studies showing reduced mortality when initiated before exhaustion.

Usage in Surgery and Critical Care

In surgical settings, is routinely employed during to ensure adequate , as impairs spontaneous and diaphragmatic function, necessitating controlled delivery of oxygen-enriched air and removal of . Positive-pressure via endotracheal is standard for most procedures exceeding short durations, with machine ventilators typically operating in volume-controlled or pressure-controlled modes to deliver tidal volumes of 6-8 mL/kg ideal body weight, guided by protective strategies to minimize intraoperative ventilator-induced injury (VILI). These ventilators differ from (ICU) models by prioritizing simplicity and integration with anesthetic delivery, often lacking advanced monitoring for prolonged support, though recent guidelines advocate low tidal volumes and (PEEP) across both environments to reduce and risks. In critical care, serves as a life-sustaining intervention for patients with , defined by criteria such as respiratory rates exceeding 30 breaths per minute, arterial below 90% despite supplemental oxygen, or inability to protect the airway due to altered mental status. Common indications include hypoxemic or hypercapnic from conditions like (ARDS), , or , with approximately 66% of initiations linked to acute and the remainder to exacerbations of chronic lung disease or complications. In the United States, over 300,000 ICU patients annually require invasive , often starting with assist-control modes and transitioning to pressure support for weaning, with settings adjusted to maintain plateau pressures below 30 cm H2O and driving pressures under 15 cm H2O to mitigate VILI. Usage patterns emphasize early intervention to reverse while monitoring for readiness via spontaneous breathing trials, though ICU mortality for ventilated patients averages 30%, varying by underlying —lower in surgical cases (around 9%) compared to medical admissions (over 40%). Transitions from operating to ICU frequently require ventilator adjustments, such as increasing PEEP or altering volumes, to address evolving pulmonary mechanics post-anesthesia. Empirical data underscore the need for protocol-driven , as higher hospital volumes correlate with improved outcomes, reflecting expertise in mode selection and complication avoidance.

Home and Long-Term Support

Home mechanical ventilation (HMV) encompasses both non-invasive and invasive modalities used to support patients with chronic in domiciliary settings, enabling prolonged independence from acute hospital care. Indications primarily include conditions such as neuromuscular diseases, (COPD) with , , and post-acute survivors requiring tracheostomy. (NIV), typically via bilevel devices, predominates for stable chronic cases due to lower infection risks and ease of use, while invasive options involve tracheostomy for those unable to tolerate masks or with bulbar dysfunction. Clinical evidence supports HMV's efficacy in improving outcomes for select patients. Systematic reviews indicate reduced hospitalization rates and enhanced in secondary to neuromuscular diseases, with one reporting a 10.5% overall quality-of-life improvement six months post-initiation. In severe hypercapnic COPD, long-term NIV reduces mortality, mitigates daytime , and lowers acute exacerbation frequency, as evidenced by randomized trials showing survival benefits over standard alone. For invasive home ventilation, detachment from support occurs in about 53.7% of prolonged cases at long-term facilities, though one-year mortality remains high at around 71% in some cohorts, underscoring selection of suitable candidates. Portable ventilators, including respiratory assist devices (RADs), facilitate mobility and home integration by providing volume- or pressure-targeted support with battery operation for up to 8-24 hours. These devices support chronic during sleep and daytime, with telemonitoring enabling remote adjustment to optimize adherence and detect desynchrony. of has risen, with U.S. estimates exceeding 100,000 users by 2012, driven by aging populations and improved device portability, though training and equipment maintenance are essential to mitigate burdens like interface discomfort and power failures. Despite benefits, not all patients achieve ventilator independence, and empirical data highlight the need for multidisciplinary follow-up to address non-respiratory comorbidities influencing long-term prognosis.

Complications and Risks

Physiological Adverse Effects

Mechanical ventilation can induce ventilator-induced lung injury (VILI), encompassing mechanisms such as from excessive airway pressures leading to alveolar rupture and , volutrauma from overdistension of lung units by high tidal volumes, atelectrauma from repetitive shear forces during alveolar collapse and reopening, and biotrauma involving from release. These injuries increase alveolar permeability, promote and hemorrhage, and impair , with rapid energy dissipation in heterogeneous lung tissue exacerbating localized damage. Incidence of varies from 5-15% in (ARDS) patients, influenced by ventilator settings like plateau pressures exceeding 30 cmH₂O. Prolonged contributes to ventilator-induced diaphragmatic dysfunction (VIDD), characterized by and reduced contractile force in muscle fibers, detectable as early as 24 hours post-initiation and progressing over the first week. This , linked to disuse and , correlates with failure and extended ventilator dependence, with ultrasound-measured thickening fraction dropping below 20% indicating weakness. Positive-pressure ventilation alters by increasing intrathoracic , which diminishes venous return and preload to the right ventricle, elevates pulmonary and right ventricular , while reducing left ventricular through decreased transmural . These changes can reduce by up to 20% in normovolemic patients, precipitating , particularly in hypovolemic or right-heart states, and may impair or renal venous drainage. Auto-positive end-expiratory (auto-PEEP) from incomplete further heightens inspiratory workload and exacerbates hemodynamic instability. Extended high fractional inspired oxygen (FiO₂ >60%) during ventilation risks , manifesting as , reduced production, and , potentially progressing to ARDS-like after 24-48 hours. Over-assistance or under-assistance in assisted modes can compound muscle dysfunction via patient-ventilator dyssynchrony, amplifying or excessive effort. Ventilator-associated pneumonia (VAP) represents the predominant infection risk in mechanically ventilated patients, with reported incidences ranging from 9% to 27% among those requiring invasive ventilation, particularly elevated in the initial five days of support. This condition arises from microbial into the lower , facilitated by endotracheal bypassing natural defenses, with risk factors including prolonged duration, male sex, history, high scores, prior exposure exceeding 48 hours, reintubation, , and advanced age. formation within endotracheal tubes exacerbates VAP pathogenesis by harboring multidrug-resistant pathogens such as , enabling persistent colonization and subsequent pneumonia development in up to 50% of prolonged cases. Ventilator circuits contribute to infection hazards through biofilm accumulation and condensate retention, where stagnant moisture promotes bacterial proliferation if circuits are not routinely changed or drained, increasing risks during patient repositioning or circuit manipulation. Microbial of circuits reveals succession toward pathogenic communities over time, underscoring the need for humidification protocols to mitigate ETT obstruction and secondary in vulnerable cohorts like patients. Additional device-linked include central line-associated and catheter-associated urinary tract infections in ventilated ICU patients, though these stem indirectly from immobility and multi-device dependency rather than ventilation circuits alone. Device-related hazards extend beyond infections to mechanical failures, with U.S. reports indicating ventilator malfunctions in 58% of adverse events, power source disruptions in 39%, and failures in 11%, potentially leading to , , or disconnection without timely detection. In ICU settings, such incidents prolong dependency and elevate mortality, compounded by user errors in rather than inherent faults in 88% of critical reports. systems introduce further risks like electrical failures and hazards from tubing degradation, though hospital-grade s prioritize to avert acute desaturation events. Preventive strategies, including regular circuit replacement and verification, demonstrably reduce these hazards, yet empirical highlight persistent gaps in adherence.

Empirical Outcomes on Morbidity and Mortality

Invasive is associated with mortality rates ranging from 40% to 60% among critically ill adults in intensive care units, with a pooled estimate of 48.61% (95% CI: 40.82-56.40%) across multiple studies. Long-term survival remains poor, with 1-year mortality reported at 59% (95% CI: 56-62%) in high-quality studies of ICU survivors. Among patients requiring prolonged (>14-21 days), 5-year mortality can reach 42%, compared to 30.4% for shorter durations. Ventilator-associated pneumonia (VAP) complicates 5-40% of cases, with incidence rates of 10-15 episodes per 1,000 ventilator-days, contributing to increased duration of and mortality. Ventilator-induced lung injury (VILI), including and biotrauma, exacerbates (ARDS), where unmitigated high tidal volumes correlate with higher mortality; protective strategies using low tidal volumes (≤6 mL/kg predicted body weight) reduce 28-day mortality from 40% to 31% and increase success. During the , patients exhibited mortality rates of 25-88%, with early cohort estimates at 29.7% overall and up to 53.7% in-hospital for ventilated cases, influenced by factors like timing of and comorbidities. Ventilator-associated events (VAEs) surged to 11.2 per 100 episodes in 2020, linked to heightened and prolonged support, though rates stabilized with protocol refinements. These outcomes underscore ventilation's role in sustaining life amid high-risk conditions but highlight persistent morbidity, including prolonged ICU stays and reduced post-discharge.

Role in Pandemics: Focus on COVID-19

Deployment Challenges and Shortages

Early in the COVID-19 pandemic, severe shortages of mechanical ventilators emerged in hotspots like Italy by March 2020, prompting rationing protocols due to insufficient units for critically ill patients with acute respiratory distress syndrome (ARDS). In the United States, pre-pandemic estimates placed the national inventory at 60,000 to 160,000 ventilators, far below projected needs amid forecasts of up to 960,000 cases requiring intensive care. By late March 2020, hospitals in New York City reported critical shortages, with some facilities resorting to shared ventilation strategies or triage decisions to allocate scarce devices. To address the crisis, the U.S. government invoked the Defense Production Act (DPA) on March 27, 2020, directing manufacturers to prioritize ventilator production and distribution. The Department of Health and Human Services (HHS) awarded contracts totaling over 187,000 units by year's end, including a $646.7 million deal with Philips for 2,500 ventilators deliverable by May 2020. Despite these efforts, deployment faced logistical hurdles: rushed production led to delays in FDA emergency use authorizations, compatibility issues with hospital systems, and shortages of essential components like filters and tubing. Beyond hardware , human resource constraints compounded challenges, as trained respiratory therapists and intensivists were overwhelmed, with expertise identified as the primary rather than machines alone. Distribution inequities arose, with urban centers receiving priority while rural hospitals lagged, exacerbating regional disparities during peak . Maintenance demands further strained systems, as high utilization rates increased failure risks without adequate spare parts, underscoring the limitations of in complex medical equipment deployment.

Protocols, Usage Patterns, and Survival Rates

Initial protocols for in patients emphasized early to manage severe and prevent aerosol spread, adapting (ARDS) guidelines with low tidal volumes of 4-6 mL/kg predicted body weight, plateau pressures below 30 cmH₂O, and (PEEP) titrated to oxygenation needs. These strategies aimed to minimize ventilator-induced lung injury while addressing the unique bilateral patterns observed, though high driving pressures often persisted due to heterogeneous . Over time, protocols evolved to prioritize non-invasive options like high-flow nasal cannula (HFNC) and (CPAP) before , driven by evidence of better outcomes in select hypoxemic patients and risks of prolonged in invasive (IMV). Adjunctive measures, including early prone positioning for at least 12-16 hours daily in awake or sedated patients, neuromuscular blockade, and corticosteroids like dexamethasone (6 mg daily for up to 10 days), became standard to improve recruitment and reduce inflammation, particularly after the trial results in June 2020. Weaning protocols focused on spontaneous breathing trials once FiO₂ requirements fell below 0.4 and PEEP below 8 cmH₂O, with tracheostomy considered after 10-14 days to facilitate liberation. Usage patterns in intensive care units (ICUs) showed wide variation, with IMV rates among hospitalized patients ranging from 29% to 89% depending on region and surge severity; early in the , up to 70-80% of ICU admissions required IMV due to conservative thresholds for . Ventilation settings typically included volume-controlled modes with respiratory rates of 20-30 breaths per minute to maintain PaCO₂ at 35-45 mmHg, though was tolerated in some cases to limit ; anesthesia machines were repurposed as ventilators in resource-limited settings per FDA guidance. Duration of IMV averaged 10-21 days, longer than in non-COVID ARDS, reflecting prolonged recovery phases. Survival rates for mechanically ventilated patients were poor overall, with meta-analyses reporting case fatality rates (CFR) of 45% (95% CI: 39-52%) across 69 studies, though rates exceeded 50% in early waves (2020) due to factors like comorbidities, delayed presentation, and initial unfamiliarity. A of nearly 1 million patients found an ICU CFR of 51.6%, with improvements to 30-40% in later periods attributable to refinements, antiviral therapies, and effects reducing viral loads. Outcomes varied by age, with patients over 65 facing 60-70% mortality, and by geography, where U.S. centers reported higher rates (up to 80%) compared to cohorts (around 40%) in adjusted analyses.

Debates on Efficacy, Overuse, and Policy Influences

Early in the , protocols in many hospitals emphasized rapid and for patients with severe respiratory distress, driven by concerns over aerosol generation from non-invasive methods and the need to protect healthcare workers. However, retrospective analyses revealed high mortality rates among ventilated patients, with case fatality rates often exceeding 80% in early cohorts; for instance, a health system study reported an 88% mortality rate among 115 patients placed on ventilators between March 1 and April 4, 2020. These outcomes fueled debates on whether ventilators were causally linked to poor survival or merely applied to the most critically ill, as underlying factors like age, comorbidities, and delayed presentation confounded results. Critics, including critical care specialists, argued that ventilators were overused, potentially exacerbating ventilator-induced lung injury (VILI) through mechanisms such as , volutrauma, and biotrauma, particularly in COVID-19-associated (ARDS), which often featured stiff, poorly recruitable lungs unlike classical ARDS. Italian intensivist Luciano Gattinoni, analyzing early European data in March 2020, contended that high-pressure ventilation mismatched the atypical pathophysiology—high compliance with profound hypoxemia—leading to unnecessary harm, and advocated for lower driving pressures and spontaneous breathing trials. Peer-reviewed studies supported this, showing that excessive tidal volumes and plateau pressures correlated with worsened outcomes, while conservative strategies like high-flow (HFNC) or prone positioning yielded lower needs and improved survival in select hypoxemic patients. By mid-2020, protocols shifted toward delaying , with U.S. ICU ventilator mortality dropping from 82% in early waves to around 40-50% in later periods, attributed to refined management rather than viral evolution alone. Policy influences amplified these issues, as initial guidelines from bodies like the CDC prioritized invasive ventilation to minimize aerosol risks, despite limited evidence, and shortages prompted ventilator stockpiling under initiatives like the U.S. Defense Production Act. Financial incentives under Medicare's provided a 20% add-on to payments for cases, with ventilator use triggering higher reimbursement codes—approximately $39,000 versus $13,000 for non-ventilated admissions—potentially encouraging aggressive intervention amid fiscal pressures on hospitals. While not direct causation for overuse, analyses noted these structures may have distorted clinical decisions, as evidenced by regional variations: high-ventilation areas like reported near-total mortality, contrasting with lower-use regions favoring non-invasive . Independent reviews, skeptical of institutional biases in protocol adoption, highlighted how media amplification of ventilator scarcity overlooked emerging data on conservative oxygenation targets (e.g., SpO2 92-96%), which reduced VILI incidence without compromising efficacy. Overall, the debates underscore a tension between empirical adaptation and policy-driven standardization, with post-hoc evidence favoring individualized, lung-protective approaches over blanket .

Recent Advancements and Future Prospects

Post-2020 Technological Innovations

In response to disruptions exposed by the , post-2020 ventilator innovations prioritized domestic manufacturing, portability, and simplified operation to enhance reliability and rapid scalability. Manufacturers developed models with modular components for easier assembly and maintenance, reducing dependency on global imports. These advancements built on lessons from emergency production efforts, incorporating robust battery systems and compact designs suitable for and field use. A notable example is the RESPOND ventilator by CorVent Medical, which received U.S. FDA 510(k) clearance on November 13, 2024, marking the first domestically produced critical care ventilator approved in over 20 years. This device supports both invasive and modes, with streamlined interfaces to minimize user errors and facilitate training in resource-limited settings. Its design emphasizes durability and cost-efficiency, addressing historical barriers to U.S. production such as regulatory hurdles and material sourcing. In July 2025, launched the Mobivent ARM, a mobile mechanical ventilator tailored for emergency transport and austere environments. This compact unit, part of the Mobivent family engineered from 2021 to 2025, features extended battery life and construction for integration into ambulances and field hospitals, enabling uninterrupted support during patient transfers. Such innovations reflect a shift toward versatile, deployable systems capable of operating without continuous power sources, improving outcomes in pre-hospital care. Emerging prototypes have also explored systems with connectivity for real-time diagnostics and parameter optimization, as demonstrated in a simulated model that integrates sensors for adaptive . These designs aim to lower costs while maintaining precision, though widespread clinical validation is ongoing. Overall, post-2020 developments underscore a focus on , with empirical testing prioritizing with standards like ISO 80601-2-12 for safety and efficacy.

Open-Source Developments

In response to ventilator shortages during the early stages of the , multiple open-source projects were initiated in 2020 to develop low-cost, rapidly producible designs using publicly available blueprints, software, and off-the-shelf components. These efforts prioritized and to enable local in resource-constrained settings, with designs often shared via platforms like for community iteration. A comprehensive review of 14 such projects identified technical feasibility in delivering basic ventilation modes, such as pressure-controlled or volume-targeted breathing, but noted incomplete documentation in areas like bill-of-materials and assembly instructions as a common barrier to replication. Prominent examples include the Emergency Ventilator (E-Vent), launched on March 12, 2020, which utilized a pneumatic system powered by compressed gas to achieve volumes of 200-800 mL at rates up to 30 breaths per minute, targeting deployment in under-resourced areas. Similarly, the University of Florida's open-source ventilator project focused on a bare-bones positive- device for adult patients, emphasizing affordability under $500 per unit through 3D-printable parts and standard electronics. Stanford's Pufferfish project advanced a full-featured capable of supporting patients across phases, incorporating safeguards like pressure alarms, with hardware files released for fabrication using controllers and valves. The OpenLung initiative, coordinated internationally, produced an emergency bag-valve-mask automation system using pumps and basic sensors, tested to deliver consistent ventilation without electricity in field conditions. Despite these innovations, few projects achieved regulatory clearance for clinical use, as open-source designs struggled with the stringent validation required for life-support devices, including testing and failure-mode analysis under standards like ISO 80601-2-12. For instance, the E-Vent relied on manufacturers to adapt and seek FDA , but no widespread deployment occurred due to integration challenges with existing hospital protocols. A evaluation of an experimental low-cost open-source ventilator highlighted its potential for global needs but restricted it to research, citing unaddressed risks like from imprecise flow control. Post-2020 developments shifted toward niche applications, such as the University of Utah's rapidly manufacturable design for austere environments, which by mid-2021 was in clinical testing for noninvasive modes with plans for regulatory submission. Complementary tools like the VentMon, an open-source inline tester released in 2021, enabled independent verification of any ventilator's performance via sensors monitoring pressure and flow, though it too awaits full certification. These initiatives demonstrated the value of distributed engineering in crises, fostering —e.g., some designs iterated from concept to bench-tested prototypes in weeks—but also exposed limitations in scaling unvetted hardware for high-stakes applications, where empirical from controlled trials remains sparse compared to systems. Ongoing repositories continue to designs, supporting future adaptations for pandemics or , though peer-reviewed outcomes emphasize the necessity of hybrid models combining with professional oversight to mitigate reliability gaps.

Integration of AI and Personalized Ventilation

Artificial intelligence (AI) integration in enables real-time analysis of patient data, such as respiratory waveforms, physiological parameters, and historical responses, to optimize ventilator settings and minimize complications like ventilator-induced injury (VILI). algorithms, including neural networks and , predict individual patient responses to adjustments in , (PEEP), and respiratory rates, facilitating automated fine-tuning that aligns with mechanics and oxygenation needs. For instance, a 2024 study employing artificial neural networks with estimated optimal ventilator parameters from clinical data, demonstrating improved alignment with protective ventilation strategies in simulated (ARDS) scenarios. Personalized ventilation leverages to tailor support based on patient-specific factors, including heterogeneity and comorbidities, diverging from one-size-fits-all protocols. models, trained on electronic health records, have simulated customized settings that reduced estimated mortality by adapting to dynamic conditions, outperforming practices in retrospective analyses of over 10,000 cases. Integration with (EIT) further enhances precision by providing regional maps, where algorithms interpret impedance changes to guide PEEP and prevent overdistension or collapse in heterogeneous s. This approach supports causal mechanisms of avoidance, as -driven adjustments correlate with lower driving pressures and better in ARDS models. AI also addresses patient-ventilator asynchrony (PVA), a common issue affecting up to 25% of ventilated patients, by detecting events like ineffective triggering or double through waveform analysis and predictive modeling. Systematic reviews of applications show high sensitivity (over 90%) in PVA identification from pressure and flow signals, enabling proactive mode switches to pressure support or adaptive algorithms that synchronize with neural respiratory drives. In weaning protocols, AI predicts extubation readiness by integrating multimodal data, with models achieving values exceeding 0.85 for successful outcomes, potentially reducing prolonged dependence. However, clinical translation remains limited; while simulations and observational studies indicate reduced complications and shorter ICU stays, prospective randomized trials are scarce, with evidence primarily from post-2020 datasets influenced by variability. Future prospects include closed-loop systems combining AI with dual-mode ventilation, which blend techniques like volume-controlled and pressure-regulated modes for seamless adaptation. Peer-reviewed evaluations highlight AI's role in resource-constrained settings by prioritizing high-risk patients and optimizing ensemble predictions from population-level data. Despite promise, challenges persist in , algorithmic interpretability, and regulatory hurdles, underscoring the need for rigorous validation to ensure causal efficacy beyond correlative gains.

References

  1. [1]
    Mechanical Ventilation - StatPearls - NCBI Bookshelf
    Mechanical ventilation is a critical intervention to sustain life in acute or emergent settings, particularly in patients with compromised airways.
  2. [2]
    What Is a Ventilator? - NHLBI - NIH
    Mar 24, 2022 · A ventilator is a machine that helps you breathe or breathes for you. Learn about how ventilators work, who needs a ventilator, and what to ...
  3. [3]
    Learning about ventilators: MedlinePlus Medical Encyclopedia
    Nov 25, 2023 · A ventilator is a machine that breathes for you or helps you breathe. It is also called a breathing machine or respirator.
  4. [4]
    Physiologic Basis of Mechanical Ventilation - ATS Journals
    May 30, 2017 · The overriding objective of mechanical ventilation is to decrease work and oxygen cost of breathing, enabling precious oxygen stores to be rerouted.
  5. [5]
    History of Mechanical Ventilation. From Vesalius to ... - ATS Journals
    Mar 2, 2015 · The origins of modern mechanical ventilation can be traced back about five centuries to the seminal work of Andreas Vesalius.Introduction to the Disco. · Introduction · Evolution of Mechanical V. · The Future
  6. [6]
    Ventilators: Three centuries in the making - University of Rochester
    Apr 11, 2020 · During the 1800s and early 1900s, negative-pressure ventilators predominated, mimicking the normal breathing process. The systems worked because ...
  7. [7]
    Optimal Strategies of Mechanical Ventilation: Can We Avoid or ...
    Jun 13, 2024 · A lung protective ventilation strategy should therefore optimize lung volume (resolve atelectasis), limit tidal volumes, and reduce oxygen exposure.Ventilator-Induced Lung... · Lung Protective Ventilation... · Weaning And Extubation<|separator|>
  8. [8]
    Positive Pressure Ventilation - StatPearls - NCBI Bookshelf
    Jan 30, 2023 · Positive pressure ventilation describes the process of either using a mask or, more commonly, a ventilator to deliver breaths and to decrease ...Continuing Education Activity · Anatomy and Physiology · Equipment · Personnel
  9. [9]
    Overview of Mechanical Ventilation - Critical Care Medicine
    In mechanical ventilation, the pressure gradient results from increased (positive) pressure of the air source. Peak airway pressure is measured at the airway ...
  10. [10]
    Basic Principles of Ventilator Design | Anesthesia Key
    Jun 13, 2016 · A mechanical ventilator is an automatic machine designed to provide all or part of the work the body must do to move gas into and out of the lungs.The Ventilator As A ``black... · Conversion And Control · The Operator Interface<|separator|>
  11. [11]
    Trends in mechanical ventilation: are we ventilating our patients in ...
    ... flow and oxygenation) and actuators to build machines reliably providing the desired pressure/flow to patients (e.g. blowers and valves). The second is the ...
  12. [12]
    Principles of Mechanical Ventilation: An Overview (2025)
    Aug 27, 2025 · The principles of mechanical ventilation include ventilation, oxygenation, respiration, lung compliance, airway resistance, and more.Lung Compliance · Airway Resistance · Respiratory Failure
  13. [13]
    Mechanical Ventilation: Principles of Action - AccessAnesthesiology
    There are two main goals of mechanical ventilation: (1) maintain appropriate levels of arterial O2 and CO2; and (2) reduce the patient's work of breathing.
  14. [14]
    [PDF] MECHANICAL VENTILATION: BASIC REVIEW
    Ventilation: the transfer of CO2 from the blood to the alveoli and out of the body. An important concept to remember: normal breathing is a negative-pressure ...
  15. [15]
    Pressure Controlled Ventilation - StatPearls - NCBI Bookshelf
    Jul 31, 2023 · It is typically available in both pressure control-continuous mandatory ventilation (PC-CMV) as well as pressure control-intermittent mandatory ...
  16. [16]
    Initial mechanical ventilation settings - WikEM
    Jan 5, 2022 · Mode. Volume-assist control · Tidal Volume. Start 6-8cc/kg predicted body weight · Inspiratory Flow Rate (comfort). More comfortable if higher ...
  17. [17]
    Mechanical Ventilation Settings - AACN
    This tool describes the common modes of positive pressure ventilation and the ventilator settings ordered for your patient with respiratory failure.
  18. [18]
    Recognized Consensus Standards: Medical Devices - FDA
    Dec 23, 2024 · This document applies to the basic safety and essential performance of a critical care ventilator in combination with its accessories, ...
  19. [19]
    ISO 80601-2-12:2023 - Medical electrical equipment — Part 2-12
    In stock 2–5 day deliveryThis document applies to the basic safety and essential performance of a critical care ventilator in combination with its accessories, hereafter referred to ...
  20. [20]
    Ventilator Alarms – Basic Principles of Mechanical Ventilation
    Standard ventilator alarms include: High Respiratory Rate, High Pressure Limit, High Volume, Low Volume, High Minute Volume, and Low Minute Volume.
  21. [21]
    Ventilator Safety - StatPearls - NCBI Bookshelf
    Mechanical ventilators are sophisticated and require training to ensure positive outcomes and limit harm. Inappropriate setting changes, failure to change ...Continuing Education Activity · Issues of Concern · Enhancing Healthcare Team...
  22. [22]
    The basics of respiratory mechanics: ventilator-derived parameters
    During mechanical ventilation, several ventilator-derived parameters should be monitored: PEEPi, Ppeak, Pplat, ΔP, PL, P0.1, PTP/min, mechanical energy, ...
  23. [23]
    The Basics of Ventilator Waveforms - PMC - NIH
    Jan 5, 2021 · Ventilator waveforms are graphical descriptions of how a breath is delivered to a patient. These include three scalars (flow versus time, volume versus time, ...
  24. [24]
    Understanding Ventilator Basics and Ventilator Waveforms | RT
    Dec 1, 2020 · This article will provide a look at many of the basic ventilator settings and examine how various waveforms and loops can be used to evaluate the effectiveness ...
  25. [25]
    Invasive Mechanical Ventilation - PMC - NIH
    Dec 1, 2019 · Components of Invasive Mechanical Ventilation. Invasive mechanical ventilation includes an endotracheal tube (ETT) and a mechanical ventilator ...
  26. [26]
    Concept design of the physical structure for ICU ventilators for ...
    Apr 28, 2021 · This manuscript aims to study the design and operational mechanics of invasive mechanical ventilators that can be employed in the hospital ...
  27. [27]
    Invasive Mechanical Ventilation: When and to whom? Indications ...
    Common indications include respiratory failure, shock, coma and operative procedures that require analgesia and sedation.
  28. [28]
    [PDF] Invasive Mechanical Ventilation - Feinberg School of Medicine
    9 A key fea- ture of AC is that the patient receives a supported breath with both patient triggered (assisted) and time triggered (controlled) breaths. Positive ...
  29. [29]
    Mechanical ventilation-associated complications and comorbidities ...
    Jul 1, 2025 · One-quarter (24.1%) of the patients experienced at least one AE. Ventilator-associated pneumonia (VAP) was the most common consequence (13%), ...
  30. [30]
    Mechanical Power: A New Concept in Mechanical Ventilation - PMC
    Mechanical ventilation is a potentially life-saving therapy for patients with acute lung injury, but the ventilator itself may cause lung injury.
  31. [31]
    Characteristics and Outcomes in Adult Patients Receiving ...
    Overall mortality rate in the intensive care unit was 30.7% (1590 patients) for the entire population, 52% (120) in patients who received ventilation because of ...
  32. [32]
    Ventilator Complications - StatPearls - NCBI Bookshelf
    VAC is defined as an increase in oxygen requirement sustained for a minimum of 2 days in a mechanically ventilated patient. Day 1, in the context of VAE, is the ...
  33. [33]
    Noninvasive Ventilation - StatPearls - NCBI Bookshelf - NIH
    Non-invasive positive pressure ventilation involves the delivery of oxygen into the lungs via positive pressure without the need for endotracheal intubation.
  34. [34]
    Noninvasive Ventilation | American Journal of Respiratory and ...
    Jun 25, 1999 · Noninvasive ventilation refers to the delivery of mechanical ventilation to the lungs using techniques that do not require an endotracheal airway.NONINVASIVE VENTILATION T. · NONINVASIVE VENTILATION F.
  35. [35]
    Non-invasive Positive Pressure Ventilation for Acute Cardiogenic ...
    Jun 13, 2021 · We found that non-invasive ventilation in the form of CPAP and BiPAP effectively reduces intubation rates, hospital mortality, and length of ...
  36. [36]
    Non-Invasive Ventilation (NIV) SID • LITFL • CCC Respiratory
    Oct 6, 2024 · Non-invasive ventilation (NIV) is the application of respiratory support via a sealed face-mask, nasal mask, mouthpiece, full face visor or ...
  37. [37]
    Noninvasive Ventilation Procedures - Medscape Reference
    Sep 23, 2024 · Noninvasive ventilation (NIV) can be defined as a ventilation modality that supports breathing without the need for intubation or surgical ...
  38. [38]
    Clinical review of non-invasive ventilation - PMC - PubMed Central
    Nov 7, 2024 · Non-invasive ventilation (NIV) is the mainstay to treat patients who need augmentation of ventilation for acute and chronic forms of respiratory failure.
  39. [39]
    Noninvasive ventilation improves the outcome in patients with ...
    NIV markedly decreases the death rate in the intensive care unit and reduces the need for intubation in patients with pneumonia-associated respiratory failure.<|separator|>
  40. [40]
    Advantages and limitations of non-invasive ventilation
    Sep 14, 2018 · Advantages and limitations of non-invasive ventilation · It does not require sedation or muscle relaxant to commence · It is tight-fitting, and ...
  41. [41]
    [PDF] Portable/Transport Ventilators: Breathe Easier - ECRI
    Portable/transport ventilators are compact, light- weight devices used to provide breathing support in a variety of applications. Today's models have longer ...
  42. [42]
    Portable ventilators - BJA Education
    Portable ventilators are lightweight, robust devices used for primary/secondary transfers, domiciliary ventilation, and in improvised intensive care facilities.
  43. [43]
  44. [44]
    What Is a Transport Ventilator? - ZOLL Medical
    Transport ventilators, also known as portable ventilators, are mechanical ventilation devices designed specifically for emergency or transport scenarios.
  45. [45]
    Transport Ventilators | Respiratory Therapy
    Today's transport ventilator technology continues to evolve to include additional monitoring, advanced modes, and enhanced alarms to promote safety.
  46. [46]
    Neonatal Ventilator - an overview | ScienceDirect Topics
    In specialty neonatal ventilators, PSV is a pressure-controlled mode that supports every spontaneous breath just like A/C but is flow-cycled.
  47. [47]
    “Current concepts in assisted mechanical ventilation in the neonate”
    Nov 16, 2020 · Modern ventilators have features to compensate for leaks, at least for inspiratory leaks. ... After the Infant Star has been withdrawn from the ...
  48. [48]
    Find Dräger Products in Neonatal Ventilators
    Advanced neonatal ventilation · Easy and efficient operation with 18.3” screen · Lung and brain protective ventilation modes · Supports developmental care-friendly ...Missing: specialized | Show results with:specialized
  49. [49]
    Neonatal Transport Ventilators: Special Features
    The key to ventilating a baby during transport depends on a blender that allows the user to dial in any O2 level and a gas line that enables access to a ...
  50. [50]
  51. [51]
    Transport Ventilators: Patient Care on the Move - Respiratory Therapy
    Transport ventilators are used in a wide spectrum of situations, including field rescue operations, accidents, and natural and man-made disasters.
  52. [52]
    [PDF] Evaluation of Various Inspiratory Times and Inflation Pressures ...
    Jan 1, 2017 · Some might contest that the first account of artificial respiration is found in the antiquity of the Holy Bible's 2 Kings 4:34, in which it ...<|separator|>
  53. [53]
    History of CPR | American Heart Association CPR & First Aid
    History of CPR · The Bellows Method first used by Swiss physician Paracelsus. The Bellows Method · 1774 · The Hall and Silvester methods become the most commonly ...
  54. [54]
    History of Mechanical Ventilation. From Vesalius to ... - PubMed
    May 15, 2015 · The origins of modern mechanical ventilation can be traced back about five centuries to the seminal work of Andreas Vesalius.
  55. [55]
    How We Help the Body Breathe
    Jun 25, 2020 · The concept of artificial ventilation dates back to ancient history, although the earliest references to it are vague and conflicting. Stories ...
  56. [56]
    History of Manual Ventilation | Desis: Senior Thesis
    Oct 21, 2021 · History of Artificial Ventilation​​ From the mid-1500s until the early 1900s, artificial ventilation techniques reported in the literature recall ...
  57. [57]
    The mechanical ventilator: past, present, and future - PubMed
    Mechanical ventilators started with negative-pressure in the 1800s, positive-pressure around 1900, and ICU ventilators in the 1940s. Future ventilators will be ...
  58. [58]
    The Iron Lung | Science Museum
    Oct 14, 2018 · The first iron lung was used at Boston Children's Hospital to save the life of an eight-year-old girl with polio in 1928. What was the iron lung ...
  59. [59]
    A practical mechanical respirator, 1929: the "iron lung" - PubMed
    Popularly named the iron lung, the Drinker respirator supported thousands of patients afflicted with respiratory paralysis during the polio era.
  60. [60]
    Lifesaving Breath | Harvard Medical School
    Oct 18, 2018 · The Warren Museum is still in search of the original prototype iron lung developed by Drinker and Shaw. “If anyone has that in storage somewhere ...
  61. [61]
    John Haven Emerson (1906–1997): The Ultimate Pioneer of ... - NIH
    Sep 22, 2024 · John Haven Emerson is recognized as a pivotal figure in the development of the “iron lung,” a mechanical respirator that played a crucial role ...
  62. [62]
    Negative Pressure Ventilation - Virtual Museum
    John Haven “Jack” Emerson (1906-1997) an American biomedical inventor did extensive work on the negative pressure respirators which became known as “iron lungs” ...
  63. [63]
    History of Negative Pressure Ventilation - Hayek Medical
    Phillip Drinker and Louis A. Shaw develop first negative pressure ventilator · Members of Harvard University faculty, Dr. Phillip Drinker and Dr. · Their device ...
  64. [64]
    The Surprisingly Long History of the Ventilator, the Machine You ...
    Jan 31, 2024 · The Pulmotor, an early device for positive pressure ventilation, was introduced in 1907 by German businessman and inventor Johann Heinrich ...
  65. [65]
    The Surprisingly Long History of the Ventilator - Time Magazine
    Apr 7, 2020 · The Pulmotor, an early device for positive pressure ventilation, was introduced in 1907 by German businessman and inventor Johann Heinrich ...Missing: pre- | Show results with:pre-<|control11|><|separator|>
  66. [66]
    Mechanical Ventilation: Past and Present - ScienceDirect.com
    Centuries later, Andreas Vesalius (1514–1546) described the technique of rhythmic inflation of an animal's lungs via a bellows attached to a tube placed in ...
  67. [67]
    Bjørn Ibsen - PMC - NIH
    The specialty of intensive care started in Copenhagen in 1952, when Bjørn Ibsen got a relay of doctors to manually ventilate a dying 12-year-old patient ...
  68. [68]
    The outbreak that invented intensive care - Nature
    Apr 3, 2020 · There were no ventilators. Very early versions of positive-pressure ventilators had been around from about 1900, used for surgery and by ...<|separator|>
  69. [69]
    In the beginning. The 1952-1953 Danish epidemic of poliomyelitis ...
    The 1952-1953 Danish epidemic of poliomyelitis and Bjørn Ibsen. Author links ... positive pressure ventilation. Acta Med Scand, 147 (1954), pp. 431-435.
  70. [70]
    Bjørn Ibsen: What Made Intensive Care So Critical? - PubMed Central
    Aug 20, 2024 · Ibsen's groundbreaking innovations, including positive pressure ventilation and real-time physiological monitoring, laid the foundation for modern intensive ...
  71. [71]
    Carl-Gunnar Engström • LITFL • Medical Eponym Library
    Nov 20, 2021 · Carl Gunnar Engström (1912 – 1987) was a Swedish physician and engineer. Engström was inventor of the first positive pressure mechanical ventilator.
  72. [72]
    Development history of modern ventilator - Product Science - 深圳普博
    Jun 13, 2020 · In 1951, Engstrom Medical in Sweden produced the first constant-volume ventilator, the Engstrom 100, which saved a large number of patients ...
  73. [73]
    Engstrom Model 150 - Wood Library-Museum of Anesthesiology
    The Engstrom Model 150 was the first mechanical ventilator that could deliver inhalation anesthetics, and was introduced in 1954.
  74. [74]
    Early ICU Ventilators - Virtual Museum
    Early ICU ventilators from the 1950s-1979 included positive pressure mechanical ventilators, labeled as "respirators", such as the Morch Respirator, Bennett PR ...
  75. [75]
    The Mechanical Ventilator: Past, Present, and Future
    However, mechanical ventilators, in the form of negative-pressure ventilation, first appeared in the early 1800s. Positive-pressure devices started to become ...<|separator|>
  76. [76]
    [PDF] It began with the Pulmotor One Hundred Years of Artificial Ventilation
    In 1982 the EV-A “Electronic Ventilator” introduced a completely new valve technology to Dräger ventilators. Electromagnetically actuated valves allowed the.
  77. [77]
    The Mechanical Ventilator: Past, Present, and Future - Sage Journals
    Aug 1, 2011 · In this review the historical development of mechanical ventilators, positive and negative pressure, invasive and noninvasive will be discussed.
  78. [78]
    [PDF] It began with the Pulmotor The History of Mechanical Ventilation
    New findings, in particular from. Scandinavia, led to positive pressure ventilation with its superior ventilation control becoming important once more. Two ...Missing: milestones | Show results with:milestones
  79. [79]
    Mechanical ventilation - Knowledge @ AMBOSS
    Apr 28, 2025 · Breath frequency and waveforms are mostly controlled by the patient. The ventilator only provides inspiratory pressure to support breathing.Missing: core | Show results with:core
  80. [80]
    Chapter 4. Indications for Mechanical Ventilation - AccessMedicine
    Apneic patients, such as those who have suffered catastrophic central nervous system (CNS) damage, need immediate institution of mechanical ventilation. To ...
  81. [81]
    Mechanical Ventilation - Medscape Reference
    Sep 15, 2020 · The positive nature of the pressure causes the gas to flow into the lungs until the ventilator breath is terminated. As the airway pressure ...<|separator|>
  82. [82]
    Indications and Options for Mechanical Ventilation - Anesthesia Key
    Jul 17, 2016 · 1 Prime indications for initiating mechanical ventilation include inadequate alveolar ventilation, inadequate arterial oxygenation, excessive ...
  83. [83]
    Management of Intraoperative Mechanical Ventilation to Prevent ...
    Mechanical ventilation (MV) is still necessary in many surgical procedures to provide gas exchanges during general anesthesia (GA) [1,2]. The concept of ...4. The Role Of Peep · 7. Respiratory Rate · 8. Expiratory Flow...
  84. [84]
    Respiratory mechanics during general anaesthesia - PMC
    In this paper we will discuss the basis of lung physiology applied to the mechanical ventilation in the operating room.Basic Physiology And... · Elastic And Resistive... · Assisted Ventilation Modes...
  85. [85]
    Chapter 49. Mechanical Ventilation in the Operating Room
    In general, ventilators in anesthesia machines are simpler than ventilators seen in an ICU setting; however, the distinction between the two is increasingly ...
  86. [86]
    Protective ventilation from ICU to operating room: state of art ... - NIH
    The motto 'low tidal volume for all' should become routine, both during major surgery and in the ICU, while application of a high positive end-expiratory ...
  87. [87]
    How Is Mechanical Ventilation Employed in the Intensive Care Unit?
    Feb 2, 1999 · Common indications for the initiation of mechanical ventilation included acute respiratory failure (66%), acute exacerbation of chronic ...
  88. [88]
    Hospital Volume and the Outcomes of Mechanical Ventilation
    It is estimated that more than 300,000 patients receive mechanical ventilation in an intensive care unit (ICU) in the United States each year; depending on the ...
  89. [89]
    A Contemporary Assessment of Acute Mechanical Ventilation... - LWW
    The ICU/hospital mortality was 27.6%/29.3%, respectively (8.5%/9.7% for surgical patients and 41.3%/43.2% for medical patients, respectively). The mean level of ...
  90. [90]
    Adjustments of Ventilator Parameters during Operating Room–to ...
    Jul 9, 2023 · This is the first study to assess the association between adjustments in mechanical ventilation parameters upon transition from the operating room to the ICU ...
  91. [91]
    Clinical Outcomes Associated with Home Mechanical Ventilation - NIH
    In summary, our systematic review suggests that HMV likely provides quality of life benefit and reduced hospitalizations in patients with CRF secondary to NMD, ...
  92. [92]
    Long-Term Noninvasive Ventilation in Chronic Stable Hypercapnic ...
    The purpose of this clinical practice guideline is to summarize the available evidence and provide actionable recommendations addressing 1) patients with COPD, ...
  93. [93]
  94. [94]
    Home mechanical ventilation: quality of life patterns after six months ...
    Aug 17, 2020 · Overall quality of life showed 10.5% improvement 6 months after initiation of home mechanical ventilation (p < 0.001). The greatest improvement ...
  95. [95]
    Home Noninvasive Ventilation in COPD - Chest Journal
    Jan 30, 2024 · Evidence is increasing that long-term noninvasive ventilation (LTNIV) can improve outcomes in individuals with severe, hypercapnic COPD.
  96. [96]
    Long-Term Outcome after Prolonged Mechanical Ventilation. A Long ...
    Jun 19, 2018 · Conclusions: Among patients receiving prolonged mechanical ventilation at an LTACH, 53.7% were detached from the ventilator at discharge and 1- ...
  97. [97]
    Outcomes of patients requiring prolonged mechanical ventilation in ...
    Other secondary outcomes include: ICU mortality of 29.7%; in-hospital mortality of 61.7%; and 1-year mortality of 71.1%. Of the 46 patients that were discharged ...Introduction · Methods · Results · Discussion<|separator|>
  98. [98]
    Home NIV treatment quality in patients with chronic respiratory ...
    The TELVENT study highlights the importance of remote NIV monitoring to rapidly identify patients with unsuccessful ventilation.
  99. [99]
    Long-Term Home Mechanical Ventilation in the United States
    Jun 1, 2012 · Improved ICU care has resulted in many patients surviving acute respiratory failure to require prolonged mechanical ventilation during ...
  100. [100]
    The treatment burden of long-term home noninvasive ventilation - NIH
    The prevalence of long-term home noninvasive ventilation (NIV) has progressively increased over recent decades, supported by evidence of clinical effectiveness ...
  101. [101]
    Mortality outcomes of patients on chronic mechanical ventilation in ...
    Indeed, our systematic review underscores that ventilator failure is rarely the cause of death for patients on home mechanical ventilation [77] and there is no ...
  102. [102]
    Ventilator-Induced Lung Injury (VILI) - StatPearls - NCBI Bookshelf
    Apr 27, 2023 · Ventilator-induced lung injury (VILI) is the acute lung injury inflicted or aggravated by mechanical ventilation during treatment.Introduction · Etiology · Evaluation · Treatment / Management
  103. [103]
    Mechanical Power and Ventilator-induced Lung Injury - ATS Journals
    Jul 28, 2023 · Damage is most likely to occur when energy is dissipated rapidly within a small volume of tissue, resulting in a high dissipation power intensity.
  104. [104]
    Volutrauma and Regional Ventilation Revisited - ATS Journals
    It is now well established that mechanical ventilation with large tidal volumes can damage the lung by distinct biophysical injury mechanisms.
  105. [105]
    Barotrauma and Mechanical Ventilation - Medscape Reference
    Feb 1, 2024 · Barotrauma is a well-recognized complication of mechanical ventilation. [1] Although most frequently encountered in patients with the acute respiratory ...Practice Essentials · Pathophysiology · Etiology · Epidemiology
  106. [106]
    Effect of Mechanical Ventilation on the Diaphragm
    Although the cause of diaphragm-muscle atrophy under conditions of controlled mechanical ventilation is not known, its clinical importance cannot be ...
  107. [107]
    Diaphragm Muscle Atrophy in the Mechanically Ventilated Patients
    Oct 23, 2011 · Diaphragm muscle atrophy starts as early as 24 hours after initiation of MV and progresses throughout at least the first week of MV.
  108. [108]
    Mechanical Ventilation–induced Diaphragm Atrophy Strongly ...
    Mar 13, 2017 · Multiple studies have shown that diaphragm weakness predicts prolonged ventilator dependence and poor clinical outcomes (7–9, 21, 22). However, ...Methods · Results · Discussion
  109. [109]
    Diaphragm Muscle Mass and Prolonged Mechanical Ventilation and ...
    Feb 19, 2020 · In mechanically ventilated patients, diaphragm weakness is associated with increased risk of prolonged ventilation, intensive care unit (ICU) ...
  110. [110]
    The cardiovascular effects of positive pressure ventilation - PMC
    The haemodynamic effects of PPV are: reduced venous return from increased intrathoracic pressure; increased PVR causing increased RV stroke work; and decreased ...
  111. [111]
    Effects of positive pressure ventilation on cardiovascular physiology
    Apr 6, 2025 · Positive pressure ventilation affects preload, afterload and ventricular compliance, and the effect in most situations is a decrease in cardiac output.
  112. [112]
    Physiological and Pathophysiological Consequences of Mechanical ...
    Apr 19, 2022 · First, hemodynamic changes can affect cardiovascular performance, cerebral perfusion pressure (CPP), and drainage of renal veins. Second, the ...
  113. [113]
    Mechanical Ventilation: State of the Art - Mayo Clinic Proceedings
    This state-of-the-art review provides an update on the basic physiology of respiratory mechanics, the working principles, and the main ventilatory settings.
  114. [114]
    Assessing breathing effort in mechanical ventilation: physiology and ...
    Abstract: Recent studies have shown both beneficial and detrimental effects of patient breathing effort in mechanical ventilation. Quantification of breathing ...Inspiratory Muscle Pump · Expiratory Muscle Pump · Excessive Breathing Effort
  115. [115]
    Trends and Factors Associated With Ventilator-Associated Pneumonia
    Mar 29, 2022 · Approximately 9% to 27% of all mechanically ventilated patients are susceptible to VAP and the risk is more predominant in the first five days ...<|separator|>
  116. [116]
    Ventilator-associated pneumonia in adults: a narrative review - PMC
    Reported incidences vary widely from 5 to 40% depending on the setting and diagnostic criteria. VAP is associated with prolonged duration of mechanical ...
  117. [117]
    Ventilator-Associated Pneumonia: Incidence, Risk Factors and ...
    The most prominent risk factors for occurrence of VAP were MOSF, prior antibiotic use for > 48 h before MV, reintubation, coma and age.
  118. [118]
    Implications of endotracheal tube biofilm in ventilator-associated ...
    Biofilm in endotracheal tubes (ETT) of ventilated patients has been suggested to play a role in the development of ventilator-associated pneumonia (VAP).
  119. [119]
    The prevention of biofilm colonization by multidrug-resistant ...
    The formation of biofilms on ETTs in intubated patients can result in ventilator-associated pneumonia. ETT plays a major role in introducing infection into the ...Missing: circuit risks
  120. [120]
    Reducing ICU Infection Risks with Silicone Ventilator Circuit Tubing
    Jun 6, 2025 · Silicone ventilator circuit tubing is reliable and protects patients from exposure to aggravating infection vectors.
  121. [121]
    Deciphering Bacterial Community Succession and Pathogen ... - MDPI
    These findings highlight the microbial risks associated with prolonged use of ventilator circuits, underscoring the need for continuous microbial surveillance ...
  122. [122]
    [PDF] Airway Humidification Guideline to Prevent ETT Biofilm in COVID-19 ...
    Summary of Key Points: • ETT biofilm build-up leading to airway obstruction has been observed in mechanically ventilated COVID patients.
  123. [123]
    Impact of Healthcare-Associated Infections Connected to Medical ...
    This review elucidates the impact of HAIs, focusing on device-associated infections such as central line-associated bloodstream infection including catheter ...
  124. [124]
    Ventilator-Related Adverse Events: A Taxonomy and Findings From ...
    The top 3 event types reported to the FDA were ventilator malfunction (58%), power source issue (39%), and alarm failure (11%). Figure 1 shows the distribution ...
  125. [125]
    Critical Incident Reports Related to Ventilator Use - PubMed Central
    Problems with ventilators occurred in only 4 cases (11.8%); in most cases, medical professionals experienced difficulty with the use or management of ...
  126. [126]
    Critical failures in the use of home ventilation medical equipment
    The failures were identified in three risk areas: device, electrical system & fire hazard, and indoor air quality.
  127. [127]
    MORTALITY AND ASSOCIATED FACTORS AMONG INTENSIVE ...
    May 1, 2024 · Results: The pooled mortality rate among adult ICU patients undergoing MV was 48.61% (95% CI: 40.82, 56.40%).
  128. [128]
    Long-term survival of critically ill patients treated with ... - PubMed
    May 20, 2015 · 39 studies reported mortality at 1 year, which was 59% (95% CI 56-62). Among the 29 high-quality studies, the pooled mortality at 1 year was 62% ...
  129. [129]
    Long-Term Outcomes and Health Care Utilization after Prolonged ...
    Oct 18, 2016 · Overall, 11,594 (5.4%) patients underwent PMV, with 42.4% of patients dying in the hospital (vs. 27.6% of patients who did not undergo prolonged ...
  130. [130]
    Epidemiology of Ventilator-Associated Pneumonia - Chest Journal
    Overall rates are most commonly 10 to 15 cases per 1,000 ventilator days for ICU patients, depending on the population studied. Also, rates are generally higher ...
  131. [131]
    Effect of a Protective-Ventilation Strategy on Mortality in the Acute ...
    Feb 5, 1998 · As compared with conventional ventilation, the protective strategy was associated with improved survival at 28 days, a higher rate of weaning ...<|separator|>
  132. [132]
    ICU and ventilator mortality among critically ill adults with COVID-19
    In a cohort of critically ill adults with COVID-19, we report an early mortality rate of 25.8% overall and 29.7% for patients who received mechanical ...
  133. [133]
    In-hospital mortality, comorbidities, and costs of one million ...
    Jun 7, 2024 · The in-hospital mortality of ventilated COVID-19 patients was 53.7% (46,553/86,729), while it was 42.6% (390,478/917,153) in non-COVID patients.
  134. [134]
    Incidence, Characteristics, and Outcomes of Ventilator-associated ...
    Mar 19, 2021 · Results: VAEs per 100 episodes of mechanical ventilation were more common in 2020 than in prior years (11.2 vs. 6.7; P < 0.01) but the rate of ...
  135. [135]
    Ventilator-Induced Lung Injury - PMC - PubMed Central
    Ventilator-induced lung injury (VILI) was proven definitively to contribute to mortality in patients with acute respiratory distress syndrome (ARDS).
  136. [136]
    A Framework for Rationing Ventilators and Critical Care Beds ...
    Mar 27, 2020 · As the coronavirus disease 2019 (COVID-19) pandemic intensifies, shortages of ventilators have occurred in Italy and are likely imminent in ...
  137. [137]
    Nationwide assessment of COVID-19 ventilator and non-invasive ...
    May 2, 2025 · An expert panel suggested that the estimated number of ventilators ranged from 60,000 to 160,000 in the United States in the early pandemic ...
  138. [138]
    Critical Supply Shortages — The Need for Ventilators and Personal ...
    Mar 25, 2020 · No matter which estimate we use, there are not enough ventilators for patients with Covid-19 in the upcoming months. Equally worrisome is the ...
  139. [139]
    Mechanical-Ventilation Supply and Options for the COVID-19 ...
    The Northeastern United States faced borderline regional shortages for mechanical ventilation during the first COVID-19 peak (18–20), and 94% of ICU beds in the ...
  140. [140]
    What is the Defense Production Act, and how is it being used in ...
    Apr 7, 2020 · On March 27, the administration announced it would use the Defense Production Act in response to COVID-19 (coronavirus).
  141. [141]
    Usage of the Defense Production Act throughout history and to ...
    Jun 3, 2020 · Two months after the DPA was invoked, HHS finalized a number of contracts to provide over 187,000 ventilators by the end of the year. See Table ...
  142. [142]
    [PDF] The Defense Production Act (DPA) and the COVID-19 Pandemic
    Apr 15, 2020 · A $646.7 million HHS contract (April 8) with Philips for 2,500 ventilators to be delivered to the Strategic National Stockpile by the end of May ...
  143. [143]
    Challenges of Ventilator Procurement and Distribution in... - LWW
    This scoping review aims to assess the literature on ventilator supply and distribution during the COVID-19 pandemic.
  144. [144]
    Challenges of Ventilator Procurement and Distribution in the ICU ...
    Mar 28, 2025 · The goal of this scoping review was to review some of the challenges hospitals faced in dealing with the shortage of ventilators during the COVID-19 pandemic.
  145. [145]
    COVID-19 Lessons Learned: Response to the Anticipated Ventilator ...
    Finally, planners realized that staff with expertise in providing mechanical ventilation were the most important shortage. Over 200,000 ventilators were ...
  146. [146]
    Mechanical-Ventilation Supply and Options for the COVID-19 ...
    Apr 9, 2020 · We provide a framework to approach the shortage of IMV resources. Here we discuss evidence and possibilities to reduce overall IMV needs.
  147. [147]
    COVID-19 pandemic and mechanical ventilation: facing the present ...
    It has since evolved from a support basically aimed at normalizing gas exchange to a technique capable of doing so, without damaging the lungs, without ...
  148. [148]
    Mechanical ventilation parameters in critically ill COVID-19 patients
    Mar 20, 2021 · This scoping review aims to provide an overview of available data about respiratory mechanics, gas exchange and MV settings in patients admitted to intensive ...
  149. [149]
    Evolution of COVID-19 management in critical care - NIH
    We conclude that COVID-19 management includes low tidal volume ventilation, early proning, steroids, and a high suspicion for secondary bacterial/fungal ...
  150. [150]
    Critical Care Management - COVID-19 Protocols
    Candidacy; Intubation Procedure; Initial Ventilator Settings; Mechanical Ventilation; Lung Protective Ventilation; ARDS Ventilation: Respiratory Rate and Tidal ...Missing: evolution | Show results with:evolution
  151. [151]
    Mechanical Ventilation in COVID-19: Interpreting the Current ...
    Rates of invasive mechanical ventilation among patients admitted to ICUs range from 29.1% in one Chinese study (3) to 89.9% in a US study (4) and anywhere from ...
  152. [152]
    [PDF] Optimizing Ventilator Use during the COVID-19 Pandemic - HHS.gov
    Mar 31, 2020 · Identifying and managing the complexities of critically ill patients are among the most challenging and unpredictable aspects of Co-Venting.
  153. [153]
    COVID-19 ICU and mechanical ventilation patient characteristics ...
    This is a comprehensive systematic review and meta-analysis of COVID-19 ICU and IMV cases and associated outcomes.
  154. [154]
    Characteristics of mechanically ventilated COVID-19 patients in the ...
    Jun 2, 2022 · The meta-analysis of 69 studies by Lim et al reported a CFR of 45% (95% CI: 39 to 52%) among mechanically ventilated COVID-19.
  155. [155]
    Intensive Care and Organ Support Related Mortality in... - LWW
    In our meta-analysis and systematic review including nearly 1 million patients with COVID-19, we found an overall ICU CFR of 37.3% and a MV CFR of 51.6%.
  156. [156]
    Survival analysis of COVID-19 versus non ... - PubMed Central - NIH
    Aug 21, 2024 · This study analyzed clinical factors impacting the survival of COVID-19 patients with acute respiratory distress síndrome, or ARDS (CARDS) ...
  157. [157]
    ICU and Ventilator Mortality Among Critically Ill Adults With ... - NIH
    ... guidelines emphasized early intubation and standard lung-protective ventilation ... Ventilators Running Out, Doctors Say the Machines Are Overused for Covid-19.
  158. [158]
    Case Fatality Rates for Patients with COVID-19 Requiring Invasive ...
    The World Health Organization reports the global crude mortality rate to be 3.9% (2). The care of critically ill patients with COVID-19 has been rapidly ...
  159. [159]
    Mechanical power normalized to aerated lung predicts noninvasive ...
    Jun 10, 2023 · Concern exists that noninvasive ventilation (NIV) may promote ventilation-induced lung injury(VILI) and worsen outcome in acute hypoxemic ...
  160. [160]
    Mortality comparison between the first and second/third waves ...
    We conducted a retrospective cohort study in adults with COVID-19 pneumonia admitted to 73 ICUs from Spain, Andorra and Ireland between February 2020 and March ...
  161. [161]
    With ventilators running out, doctors say the machines are overused ...
    Apr 8, 2020 · With ventilators running out, doctors say the machines are overused for COVID-19. A fuel cell stack testing engineer tests ventilator oxygen ...
  162. [162]
    Are DRG-based Reimbursements Appropriate for COVID-19?
    Aug 7, 2020 · Current healthcare reimbursements may create incentives for excess use of ventilators to treat COVID-19 patients.
  163. [163]
    Fact check: Do hospitals get paid 'more' to treat COVID-19 patients?
    Jun 22, 2020 · Medicare has determined that a hospital gets paid $13,000 if a COVID-19 patient on Medicare is admitted and $39,000 if the patient goes on a ...
  164. [164]
    The Reign of the Ventilator: Acute Respiratory Distress Syndrome ...
    May 4, 2021 · 1. Williams M. Ventilators are being overused on COVID-19 patients, world-renowned critical care specialist says. CBC News. 17 April 2020.
  165. [165]
    CorVent wins FDA clearance for Respond critical care ventilator
    Nov 20, 2024 · CorVent Medical announced today that it received FDA 510(k) clearance for its Respond critical care ventilator system.
  166. [166]
    K241135 - 510(k) Premarket Notification - FDA
    Nov 13, 2024 · RESPOND(R) Ventilator. Applicant. CorVent Medical, Inc. 1805 NDSU ... Date Received, 04/24/2024. Decision Date, 11/13/2024. Decision ...Missing: clearance | Show results with:clearance
  167. [167]
    CorVent Medical's Respond Ventilator Gets FDA Nod - 24X7mag
    “This marks a significant milestone as it is the first U.S.-manufactured ventilator to receive FDA clearance in over 20 years,” says Richard S. Walsh, president ...<|separator|>
  168. [168]
    FDA Clears CorVent's Respond Ventilator - Respiratory Therapy
    CorVent Medical's Respond ventilator, offering both invasive and non-invasive capabilities, has received FDA 510(k) clearance.
  169. [169]
    CorVent Medical Earns FDA 510(k) Clearance for RESPOND ...
    Nov 19, 2024 · CorVent Medical, a medical device and mechanical ventilator manufacturer, announced that its RESPOND ventilator has received US FDA 510(k) clearance.
  170. [170]
    Rostec Brought to Market the Mobivent ARM, a New Mobile ... - Ростех
    Jul 17, 2025 · The Mobivent ARM is included in the Mobivent mechanical ventilator family designed in 2021-2025. It includes five products: General-purpose ...
  171. [171]
    An Innovative Embedded Ventilator for Accessible and Intelligent ...
    Feb 15, 2025 · In this study, a simulated model for an affordable smart innovative ventilator with internet of things (IoT) capabilities is presented.
  172. [172]
    A review of open source ventilators for COVID-19... | F1000Research
    To be open source a ventilator project needs to include: 1) the design source files (e.g. computer aided design or CAD), which are needed to iterate on the ...
  173. [173]
    PubInv/covid19-vent-list: A list projects to make emergency ... - GitHub
    An analyzed list of projects to make emergency ventilators in response to COVID-19, focusing on free-libre open source.
  174. [174]
    A review of open source ventilators for COVID-19 and ... - PubMed
    Mar 30, 2020 · These articles are analyzed to determine if the designs are open source both in spirit (license) as well as practical details (e.g. possessing ...
  175. [175]
    MIT-based team works on rapid deployment of open-source, low ...
    Mar 26, 2020 · The team, called MIT E-Vent (for emergency ventilator), was formed on March 12 in response to the rapid spread of the Covid-19 pandemic.
  176. [176]
    Open-Source Ventilator Project
    This open-source project has been created to address predicted ventilator shortage worldwide due to the COVID-19 pandemic and host open-source contributions.
  177. [177]
    Pufferfish: Open-Source Full-Featured Ventilator | Bioengineering
    We are developing an open-source ventilator that can support a COVID19 patient throughout the treatment and yet is simple to manufacture and can be built easily ...
  178. [178]
    Experimental Open-source Low-cost Ventilator Could Meet Critical ...
    Jun 21, 2022 · The open-source device, which is not FDA authorized and is currently recommended for research use only, could help meet the global need for a ...
  179. [179]
    A Rapidly Manufacturable, Open-Source Ventilator for Austere ...
    Jul 1, 2021 · An initial version focusing on noninvasive ventilation is currently undergoing clinical testing and preparation for regulatory approval in ...
  180. [180]
    VentMon: An open source inline ventilator tester and monitor
    The VentMon is a modular, open source, IoT-enabled tester that plugs into a standard 22 mm airway between a ventilator and a physical test lung to test any ...
  181. [181]
    Low-Cost, Open-Source Mechanical Ventilator with Pulmonary ...
    This paper shows the construction of a low-cost, open-source mechanical ventilator. The motivation for constructing this kind of ventilator comes from the ...
  182. [182]
    Advances in Machine Learning for Mechanically Ventilated Patients
    Jun 21, 2025 · The study established a pneumatic model of the mechanical ventilation system and proposed a new fuzzy control method for the ventilator support ...
  183. [183]
    Artificial Intelligence for Mechanical Ventilation - Sage Journals
    Nov 11, 2024 · AI can offer personalized treatments, reduce complications, improve efficiency, and assist in decision-making for mechanical ventilation, ...
  184. [184]
    Mechanical Ventilator Settings Estimation From an AI Model
    Oct 24, 2024 · In this study, an AI (artificial intelligence) model using artificial neural networks (ANNs) along with Bayesian Optimization (BO) was developed to estimate ...
  185. [185]
    Reinforcement Learning to Optimize Ventilator Settings for Patients ...
    Oct 16, 2024 · Our study found that customizing ventilation settings for individual patients led to lower estimated hospital mortality rates compared to actual rates.
  186. [186]
    Role of artificial intelligence in enhancing mechanical ventilation
    Aug 7, 2025 · AI integration enhances EIT diagnostic capabilities, facilitating the development of personalized treatment plans. This synergy fosters ...<|separator|>
  187. [187]
    AI reshapes ARDS care by predicting risk, guiding ventilation, and ...
    Jul 21, 2025 · To summarize, current evidence shows that AI and ML can detect ARDS earlier, stratify risk more precisely, tailor ventilation to individual lung ...Early Warning: Predicting... · Phenotypes And Endotypes · Smarter Breathing Support
  188. [188]
    Application progress of machine learning in patient-ventilator ...
    Jul 10, 2025 · This systematic review demonstrates the significant potential of ML models for the automated identification and prediction of PVA. Despite ...
  189. [189]
    Artificial intelligence in the management of patient-ventilator ...
    AI enhances PVA detection, prediction, and optimization, enabling real-time detection, improved weaning prediction, and personalized ventilatory strategies.
  190. [190]
    Artificial intelligence for mechanical ventilation: systematic review of ...
    Artificial intelligence (AI) has the potential to personalise mechanical ventilation strategies for patients with respiratory failure.
  191. [191]
    Artificial intelligence in respiratory care - Frontiers
    To offer personalized ventilation, dual-mode ventilation integrates inbuilt AI algorithms to combine distinct ventilation techniques, such as pressure support ...
  192. [192]
    Unveiling the Influence of AI on Advancements in Respiratory Care
    Dec 20, 2024 · Artificial intelligence has the potential to facilitate individualized mechanical ventilation by using comprehensive patient and population data ...
  193. [193]
    Exploring the Potential of Machine Learning in Optimizing ... - AJMC
    Aug 9, 2025 · Machine learning can enhance ARF outcome predictions but faces challenges like data quality, system heterogeneity, and clinician acceptance.